Gland Pharma has reported results for first quarter ended June 30, 2026 (Q1FY27).
The company has reported 35.33% jump in its net profit at Rs 364.39 crore for the quarter ended June 30, 2026 as compared to Rs 269.26 crore for the same quarter in the previous year. The total income of the company has increased by 23.03% at Rs 1,345.46 crore for Q1FY27 as compared to Rs 1,093.58 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 47.09% jump in its net profit at Rs 316.96 crore for Q1FY27 as compared to Rs 215.48 crore for the same quarter in the previous year. The total income of the company has increased by 19.09% at Rs 1,861.50 crore for Q1FY27 as compared to Rs 1,563.15 crore for the corresponding quarter previous year.
